Nalaganje...
Impact of Different JAK Inhibitors and Methotrexate on Lymphocyte Proliferation and DNA Damage
Janus kinase inhibitors (JAKis) represent a new strategy in rheumatoid arthritis (RA) therapy. Still, data directly comparing different JAKis are rare. In the present in vitro study, we investigated the immunomodulatory potential of four JAKis (tofacitinib, baricitinib, upadacitinib, and filgotinib)...
Shranjeno v:
| izdano v: | J Clin Med |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8036268/ https://ncbi.nlm.nih.gov/pubmed/33916057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10071431 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|